Clarke, 2006
Araki, 2000, Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms, J Urol, 164, 1640
Blackett, 2009, Urinary dysfunction in Parkinson's disease: a review, Parkinsonism Relat Disord, 15, 81, 10.1016/j.parkreldis.2007.10.016
McVary, 1998, Prostate innervation, Prostate, 8, 2, 10.1002/(SICI)1097-0045(1998)8+<2::AID-PROS2>3.0.CO;2-U
Seki, 2001, Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats, Neurourol Urodyn, 20, 105, 10.1002/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9
Berry, 1984, The development of human benign prostatic hyperplasia with age, J Urol, 132, 474
Stenman, 1997, Prostate-specific antigen, clinical use and staging: an overview, Br J Urol, 79, 53, 10.1111/j.1464-410X.1997.tb00802.x
Pannek, 2003, Prostate size and PSA serum levels in male patients with spinal cord injury, Urology, 62, 845, 10.1016/S0090-4295(03)00654-X
Zermann, 2000, Central nervous system neurons labeled following the injection of pseudorabies virus into the rat prostate gland, Prostate, 44, 240, 10.1002/1097-0045(20000801)44:3<240::AID-PROS9>3.0.CO;2-9
Chaudhuri, 2006, Non-motor symptoms of Parkinson's disease: diagnosis and management, Lancet Neurol, 5, 235, 10.1016/S1474-4422(06)70373-8
Sakakibara, 2001, Questionnaire based assessment of pelvic organ dysfunction in Parkinson's disease, Auton Neurosci, 92, 76, 10.1016/S1566-0702(01)00295-8
Wenning, 2003, Multiple system atrophy: an update, Mov Disord, 18, 34, 10.1002/mds.10561
Fowler, 2008, The neural control of micturition, Nat Rev Neurosci, 9, 453, 10.1038/nrn2401
Christmas, 1988, Role of subcutaneous apomorphine in parkinsonian voiding dysfunction, Lancet, 2, 1451, 10.1016/S0140-6736(88)90932-4
Shim, 2006, Prostate activity and prostate cancer in spinal cord injury, Prostate Cancer Prostatic Dis, 9, 115, 10.1038/sj.pcan.4500865
Shim, 2008, Prostate-specific antigen and prostate volume in Korean men with spinal cord injury: a case-control study, Spinal Cord, 46, 11, 10.1038/sj.sc.3102051